Makronix Life Sciences Private Limited

GODAPA THE MOST RELIABLE SGLT-2 INHIBITOR 
THE U.S FOOD AND DRUG ADMINISTRATION APPROVE DAPAGLIFLOZINE ORAL TABLETS FOR ADULTS WITH HEARTS FAILURE WITH REDUCED EJECTION FRACTION TO REDUCE THE RISK OF CARDIOVASCULAR DEATH AND HOSPITALIZATION FOR HEART FAILURE.
GODAPA CAN  BE USED IN COMBINATOIN  WITH INSULIN IN APPROPRIATE PATIENTS WITH TYPE 2 DIABETES. 
ENSURES VICTORY IN CONTROLLING DIABETES.
GODAPA MAKES DIABETICS PATIENTS TO LOSE WEIGHT.AND IN ADDITION WITH METFORMIN LOST ABOUT 4 AND 1/2 MORE POUNDS THAN THOSE TAKING METFORMIN ALONE IN THE 24- WEEK STUDY.
TYPE-2 DIABETES MELLITUS ALONG WITH CARDIOVASCULAR DISEASES.